Stock Ideas
New
Stocks
Funds
Screener
Sectors
Watchlists
TKNO

TKNO - Alpha Teknova, Inc. Stock Price, Fair Value and News

1.96USD+0.06 (+3.16%)Market Closed

Market Summary

TKNO
USD1.96+0.06
Market Closed
3.16%

TKNO Stock Price

View Fullscreen

TKNO RSI Chart

TKNO Valuation

Market Cap

80.0M

Price/Earnings (Trailing)

-2.22

Price/Sales (Trailing)

2.17

EV/EBITDA

-2.33

Price/Free Cashflow

-3.74

TKNO Price/Sales (Trailing)

TKNO Profitability

EBT Margin

-98.70%

Return on Equity

-43.25%

Return on Assets

-29.85%

Free Cashflow Yield

-26.77%

TKNO Fundamentals

TKNO Revenue

Revenue (TTM)

36.9M

Rev. Growth (Yr)

1.85%

Rev. Growth (Qtr)

18.09%

TKNO Earnings

Earnings (TTM)

-36.1M

Earnings Growth (Yr)

8.13%

Earnings Growth (Qtr)

23.99%

Breaking Down TKNO Revenue

Last 7 days

8.9%

Last 30 days

-7.1%

Last 90 days

-38.0%

Trailing 12 Months

-5.8%

How does TKNO drawdown profile look like?

TKNO Financial Health

Current Ratio

5.52

Debt/Equity

0.16

Debt/Cashflow

-1.34

TKNO Investor Care

Shares Dilution (1Y)

44.78%

Diluted EPS (TTM)

-1.05

Historical Charts for Stock Metrics

Get all data in R, Python etc through our Historical Stock Data APIs
Net sales
YearQ1Q2Q3Q4
202436.9M000
202339.4M39.2M36.7M36.7M
202239.0M42.3M43.6M41.4M
202132.7M34.1M35.5M36.9M
202000031.3M

Tracking the Latest Insider Buys and Sells of Alpha Teknova, Inc.

Filter Transactions
Datesorted ascendingNameBuy/Sell$ ValueAvg. Price# SharesTitle
Nov 30, 2023
gelhaus ken
bought
6,219
1.734
3,587
chief commercial officer
Nov 14, 2023
hood lisa
sold
-
-
-15,000
chief people officer
Sep 19, 2023
mackowski j matthew
bought
1,500,000
1.85
810,810
-
Sep 19, 2023
telegraph hill partners iv, l.p.
bought
2,202,000
1.85
1,190,270
-
Sep 19, 2023
telegraph hill partners iv, l.p.
bought
12,798,000
1.85
6,917,840
-
Sep 19, 2023
terrill damon
bought
49,999
1.85
27,027
general counsel and cco
Sep 19, 2023
gunstream stephen
bought
99,999
1.85
54,054
president and ceo
Sep 19, 2023
lowell matthew
bought
99,999
1.85
54,054
chief financial officer
Aug 31, 2023
mcnamara robert
back to issuer
-
-
-18,815
-
Jun 13, 2023
hood lisa
sold
-43,267
3.7954
-11,400
chief people officer

1–10 of 47

Which funds bought or sold TKNO recently?

View All Details
Datesorted ascendingFund NameType% Chg$ Change$ Held% Portfolio
May 16, 2024
FourWorld Capital Management LLC
new
-
135,222
135,222
0.09%
May 16, 2024
JANE STREET GROUP, LLC
sold off
-100
-38,911
-
-%
May 15, 2024
Tower Research Capital LLC (TRC)
added
112
5,921
17,551
-%
May 15, 2024
Royal Bank of Canada
reduced
-24.59
-
-
-%
May 15, 2024
OSTERWEIS CAPITAL MANAGEMENT INC
new
-
716,216
716,216
0.04%
May 15, 2024
BRIDGEWAY CAPITAL MANAGEMENT, LLC
unchanged
-
-84,000
177,100
-%
May 15, 2024
MILLENNIUM MANAGEMENT LLC
added
1.2
-2,117,550
4,635,630
-%
May 15, 2024
683 Capital Management, LLC
sold off
-100
-149,543
-
-%
May 15, 2024
Redmile Group, LLC
added
6.49
-166,773
433,776
0.02%
May 15, 2024
BOOTHBAY FUND MANAGEMENT, LLC
sold off
-100
-38,415
-
-%

1–10 of 38

Are Funds Buying or Selling TKNO?

Are funds buying TKNO calls or puts?
Calls
Puts
No. of funds holding Calls - Puts
Net Call Options
No. of funds that own TKNO
No. of Funds

Unveiling Alpha Teknova, Inc.'s Major ShareHolders

Date FiledName of FilerPercent of ClassNo. of SharesForm Type
Feb 14, 2024
telegraph hill partners iv, l.p.
62.9%
25,620,792
SC 13G/A
Oct 06, 2023
telegraph hill partners iv, l.p.
62.9%
25,620,792
SC 13G/A
Feb 14, 2022
davis ted
-
0
SC 13G
Feb 14, 2022
telegraph hill partners iv, l.p.
62.5%
17,512,685
SC 13G

Recent SEC filings of Alpha Teknova, Inc.

View All Filings
Date Filed Form Type Document
May 13, 2024
8-K
Current Report
May 13, 2024
10-Q
Quarterly Report
Apr 29, 2024
DEFA14A
DEFA14A
Apr 29, 2024
DEF 14A
DEF 14A
Apr 29, 2024
ARS
ARS
Apr 02, 2024
8-K
Current Report
Mar 27, 2024
S-8
Employee Benefits Plan
Mar 27, 2024
10-K
Annual Report
Mar 11, 2024
8-K
Current Report
Feb 27, 2024
4
Insider Trading

Peers (Alternatives to Alpha Teknova, Inc.)

NameMkt Capsorted ascendingRevenuePrice %, 1MReturns, 1YP/EP/SRev 1-YrInc 1-Yr
LARGE-CAP
372.2B
85.6B
6.82% -1.69%
9.67
4.35
5.68% 202.39%
332.3B
61.4B
4.65% 15.09%
144.1
5.41
6.11% -82.30%
167.7B
29.5B
18.35% 39.38%
44.55
5.68
12.76% -52.47%
162.3B
57.8B
12.71% -21.46%
129.52
2.81
76.51% -86.81%
84.4B
27.4B
1.23% -13.37%
174.21
3.07
1.51% -91.32%
18.4B
16.0B
23.52% 97.09%
-37.29
1.15
7.23% 71.10%
MID-CAP
4.1B
1.7B
0.67% -19.91%
9.41
2.37
54.01% 364.56%
4.1B
4.6B
-0.70% -10.77%
-528.11
0.89
-0.06% 94.55%
2.5B
9.0B
-21.94% -21.03%
-5.45
0.28
10.01% -27.45%
2.1B
676.2M
8.56% -0.82%
13.75
3.14
30.38% 66.04%
SMALL-CAP
1.5B
743.2M
15.12% -18.85%
-4.35
2.06
24.65% 80.36%
25.8M
1.3M
18.52% -47.17%
-3.49
19.84
-98.14% -104.71%
18.4M
89.6M
6.93% 25.60%
-1.29
0.19
287.27% -129.41%
2.5M
21.5M
2.70% -90.89%
-0.32
0.12
66.16% 61.83%
633.5K
115.7M
-50.00% -97.38%
0
0.01
-2.22% -352.48%

Alpha Teknova, Inc. News

Latest updates
MarketBeat15 May 202405:09 pm
MarketBeat14 May 202406:53 pm
Yahoo Movies UK13 May 202411:53 pm
Investing.com India13 May 202409:50 pm
Houston Chronicle 13 May 202407:00 am

Alpha Teknova, Inc. Earnings Report: Key Takeaways & Analysis

Income Statement (Last 12 Months)
Income Statement (Quarterly)
Description(%) Q/Q2024Q12023Q42023Q32023Q22023Q12022Q42022Q32022Q22022Q12021Q42021Q32021Q22021Q12020Q42020Q32020Q2
Revenue18.1%9,290,0007,867,0008,169,00011,527,0009,121,0007,891,00010,692,00011,690,00011,147,00010,110,0009,392,0008,313,0009,078,0009,031,0008,984,0006,044,000
Gross Profit65.5%2,209,0001,335,0001,472,0005,066,0002,423,0002,110,0004,770,0005,247,0005,349,0004,979,0004,263,0003,354,0005,025,000-5,088,0003,469,000
Operating Expenses-16.4%10,195,00012,193,00010,234,00012,063,00011,369,00016,346,00027,724,00011,873,00011,192,0009,745,5008,151,0005,880,0005,853,000-2,936,0002,765,000
  S&GA Expenses-30.6%1,667,0002,401,0002,412,0002,174,0002,343,0002,559,0002,397,0002,598,0001,597,0001,283,000885,000904,000705,000-558,000481,000
  R&D Expenses-34.4%860,0001,311,0001,397,0001,464,0001,395,0001,870,0001,925,0001,929,0002,013,0001,389,5001,372,000851,000700,000-358,000341,000
EBITDA Margin5.0%-0.83-0.88-0.98-1.25-1.23-1.11-0.85-0.44-0.39-0.280.190.200.210.22--
Interest Expenses111.6%366,000173,000-791,000-308,00093,000128,00070,00028,000-13,000-36,500-255,000-304,0007,000-19,000-
Income Taxes88.8%-34,000-304,0009,00015,000-18,000-786,000-374,000-400,000-400,000-1,205,500-892,000-600,000-165,000-636,000200,000
Earnings Before Taxes25.8%-8,131,000-10,960,000-10,144,000-7,139,000-8,835,000-14,089,000-22,848,000-6,598,000-5,856,000-4,841,000-4,143,000-2,833,000-820,000-2,169,000723,000
EBT Margin2.3%-0.99-1.01-1.10-1.35-1.33-1.19-0.92-0.51-0.45-0.340.130.140.140.15--
Net Income24.0%-8,100,000-10,656,000-10,153,000-7,154,000-8,817,000-13,294,000-22,474,000-6,203,000-5,497,000-3,647,000-3,251,000-2,250,000-655,000-1,533,000512,000
Net Income Margin2.4%-0.98-1.00-1.07-1.32-1.29-1.15-0.87-0.44-0.38-0.270.100.100.110.11--
Free Cashflow-108.2%-6,670,000-3,204,000-5,354,000-6,194,000-11,996,000-12,759,000-14,914,000-16,758,000-11,118,000-10,494,000-8,744,000-8,225,000-1,483,000---
Balance Sheet
(In Millions)
Balance Sheet
(In Millions)
(*) denotes actual numbers (not divided by Millions)
Description(%) Q/Q2024Q12023Q42023Q32023Q22023Q12022Q42022Q32022Q22022Q12021Q42021Q32021Q22020Q4
Assets-6.0%12112913813314115216018218416716917363.00
  Current Assets-15.0%39.0046.0051.0043.0050.0061.0070.0080.0092.0010111111816.00
    Cash Equivalents-24.2%22.0029.0032.0024.0030.0042.0050.0065.0076.0088.0098.001083.00
  Inventory-3.3%11.0012.0011.0012.0012.0012.0010.008.006.005.004.004.004.00
  Net PPE-2.9%49.0050.0052.0053.0054.0052.0053.0047.0037.0030.0022.0018.0010.00
  Goodwill--------17.0017.0017.0017.0017.0017.00
Liabilities-2.9%37.0039.0039.0046.0049.0052.0048.0049.0046.0023.0023.0024.0011.00
  Current Liabilities-20.7%7.009.008.0029.009.0011.0012.0012.0013.008.006.006.004.00
  Long Term Debt-0.6%13.0013.0013.00-22.0022.0017.0017.0012.0012.0012.0012.00-
    LT Debt, Current----22.00---------
    LT Debt, Non Current---13.00--22.00-------
Shareholder's Equity-7.4%83.0090.0010086.0092.0010011213313914314614917.00
  Retained Earnings-8.8%-99.90-91.79-81.10-70.98-63.82-55.01-41.71-19.24-13.03-7.54-3.89-0.642.00
  Additional Paid-In Capital0.8%18318218115715615515415315215115015014.00
Shares Outstanding0.1%41.0041.0041.0028.0028.0028.0028.0028.0028.0028.0012.004.004.00
Float----19.00---59.00---164-
Cashflow (Last 12 Months)
(In Thousands)
Cashflow (Quarterly)
(In Thousands)
(*) denotes actual numbers (not divided by Thousands)
Description(%) Q/Q2024Q12023Q42023Q32023Q22023Q12022Q42022Q32022Q22022Q12021Q42021Q32021Q22021Q12020Q42020Q32020Q2
Cashflow From Operations-126.8%-6,558-2,892-4,382-3,856-7,684-8,029-8,332-5,838-5,201-3,082-4,837-3,5512,401---
  Share Based Compensation27.9%1,3071,0221,0351,0701,0101,022968934787624442302183---
Cashflow From Investing111.3%13.00-115-972-2,338-4,312-4,730-6,582-10,920-5,917-7,412-3,907-4,674-1,528---
Cashflow From Financing44.8%-343-62113,625-180-25.005,14035.005,03755.00-1.00-1,265101,78110,278---
Get Full Access to Grufity – and Unlimited Downloads
Gain full access to fair value, watchlists, stock screener, unlimited page visits, and additional features by joining as a member today for just $1.99.
Try For Just $1.99

TKNO Income Statement

2024-03-31
Condensed Statements of Operations (Unaudited) - USD ($)
$ in Thousands
3 Months Ended
Mar. 31, 2024
Mar. 31, 2023
Income Statement [Abstract]  
Revenue$ 9,290$ 9,121
Cost of sales7,0816,698
Gross profit2,2092,423
Operating expenses:  
Research and development8601,395
Sales and marketing1,6672,343
General and administrative7,3817,345
Amortization of intangible assets287286
Total operating expenses10,19511,369
Loss from operations(7,986)(8,946)
Other (expenses) income, net  
Interest (expense) income, net(145)93
Other income, net018
Total other (expenses) income, net(145)111
Loss before income taxes(8,131)(8,835)
Benefit from income taxes(34)(18)
Net loss$ (8,097)$ (8,817)
Net loss per share basic and diluted$ (0.2)$ (0.31)
Net loss per share basic and diluted$ (0.2)$ (0.31)
Weighted average shares used in computing net loss per share -basic40,804,88528,181,457
Weighted average shares used in computing net loss per share- diluted40,804,88528,181,457

TKNO Balance Sheet

2024-03-31
Condensed Balance Sheets (Unaudited) - USD ($)
$ in Thousands
Mar. 31, 2024
Dec. 31, 2023
Current assets:  
Cash and cash equivalents$ 21,596$ 28,484
Accounts receivable, net of allowance for doubtful accounts of $23 thousand and $20 thousand as of March 31, 2024 and December 31, 2023, respectively4,5603,948
Inventories, net11,20711,594
Prepaid expenses and other current assets1,4601,634
Total current assets38,82345,660
Property, plant and equipment, net48,90750,364
Operating right-of-use lease assets17,40016,472
Intangible assets, net13,95214,239
Other non-current assets1,7351,852
Total assets120,817128,587
Current liabilities:  
Accounts payable1,5431,493
Accrued liabilities3,5745,579
Current portion of operating lease liabilities1,9221,803
Total current liabilities7,0398,875
Deferred tax liabilities884919
Other accrued liabilities78102
Long-term debt, net13,17813,251
Long-term operating lease liabilities16,26015,404
Total liabilities37,43938,551
Stockholders’ equity:  
Preferred stock, $0.00001 par value, 10,000,000 shares authorized at March 31, 2024 and December 31, 2023, respectively, zero shares issued and outstanding at March 31, 2024 and December 31, 202300
Common stock, $0.00001 par value, 490,000,000 shares authorized at March 31, 2024 and December 31, 2023, 40,823,387 and 40,793,848 shares issued and outstanding at March 31, 2024 and December 31, 2023, respectively00
Additional paid-in capital183,261181,822
Accumulated deficit(99,883)(91,786)
Total stockholders’ equity83,37890,036
Total liabilities and stockholders' equity$ 120,817$ 128,587
TKNO
Alpha Teknova, Inc. produces critical reagents for the research, discovery, development, and commercialization of novel therapies, vaccines, and molecular diagnostics. The company offers pre-poured media plates for cell growth and cloning; liquid cell culture media and supplements for cellular expansion; and molecular biology reagents for sample manipulation, resuspension, and purification. It serves life sciences market, including pharmaceutical and biotechnology companies, contract development and manufacturing organizations, in vitro diagnostic franchises, and academic and government research institutions. The company was founded in 1996 and is headquartered in Hollister, California.
 CEO
 WEBSITEteknova.com
 INDUSTRYPharmaceuticals
 EMPLOYEES285

Alpha Teknova, Inc. Frequently Asked Questions


What is the ticker symbol for Alpha Teknova, Inc.? What does TKNO stand for in stocks?

TKNO is the stock ticker symbol of Alpha Teknova, Inc.. Every public company that trades on a stock exchange gets a ticker symbol.

What is the market capital of Alpha Teknova, Inc. (TKNO)?

As of Fri May 17 2024, market cap of Alpha Teknova, Inc. is 80.01 Million. The market capitalization is calculated by multiplying the stock price with the number of shares outstanding.

What is the fair value of TKNO stock?

You can check TKNO's fair value in chart for subscribers.

What is the fair value of TKNO stock?

You can check TKNO's fair value in chart for subscribers. The fair value of Alpha Teknova, Inc. is provided for various growth and macro-economic scenarios from very pessimiatic to very optimistic assumptions. These fair values are estimates from Grufity's Fair Value model based on company's past performance. However, past performance of Alpha Teknova, Inc. is no guarantee of future performance. These fairvalue estimates should only be used as one of the inputs in your stock analysis. We provide model's historical fair value estimates for TKNO so that you know how good or bad the model has been in the past so you can discard it if needed. There are others that provide fair values of stocks such as wallmine, finbox, gurufocus and finviz. Most provide point in time estimates. We provide a history of our models fair value estimates so that you can get a sense of it's usefulness. Otherwise this data point is of little use.

Is Alpha Teknova, Inc. a good stock to buy?

The fair value guage provides a quick view whether TKNO is over valued or under valued. Whether Alpha Teknova, Inc. is cheap or expensive depends on the assumptions which impact Alpha Teknova, Inc.'s fair value. We provide several scenarios of inflation and growth to encompass these range of assumptions for TKNO.

What is Alpha Teknova, Inc.'s Price to Earnings (PE) and Price to sales (PS) ratio?

As of Fri May 17 2024, TKNO's PE ratio (Price to Earnings) is -2.22 and Price to Sales (PS) ratio is 2.17. The price to earnings and price to sales ratio are two most important valuation metrics for any company. PE ratio tell us the number of years of earnings investors are ready to pay for owning the company. Historically, S&P500 price to earnings ratio has fallen below 12 during periods of gloom and gone past 30 during periods of euphoria. TKNO PE ratio will change depending on the future growth rate expectations of investors.